Catalysts for Novitium Pharma LLC
53 tracked
Apr 13, 2026
approval
PIMOZIDE — FDA approval
PIMOZIDE
→
Apr 2, 2026
approval
ACETAZOLAMIDE — FDA approval
ACETAZOLAMIDE
→
Feb 10, 2026
approval
FLUDROCORTISONE ACETATE — FDA approval
Novitium Pharma LLC
→
Feb 3, 2026
approval
ALENDRONATE SODIUM — FDA approval
ALENDRONATE SODIUM
→
Feb 2, 2026
approval
MIRTAZAPINE — FDA approval
mirtazapine ODT
→
Jan 26, 2026
approval
TAPENTADOL HYDROCHLORIDE — FDA approval
tapentadol hydrochloride ER
→
Jan 20, 2026
approval
SERTRALINE HYDROCHLORIDE — FDA approval
SERTRALINE HYDROCHLORIDE
→
Dec 22, 2025
approval
LEVORPHANOL TARTRATE — FDA approval
LEVORPHANOL TARTRATE
→
Dec 22, 2025
approval
BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE (ASPIRIN) — FDA approval
BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE
→
Dec 22, 2025
approval
BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE (ASPIRIN) — FDA approval
Novitium Pharma LLC
→
Dec 22, 2025
approval
BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE (ASPIRIN) — FDA approval
Novitium Pharma LLC
→
Dec 16, 2025
approval
HYDROXYZINE HYDROCHLORIDE — FDA approval
HYDROXYZINE HYDROCHLORIDE
→
Dec 10, 2025
approval
OMEPRAZOLE AND SODIUM BICARBONATE (OMEPRAZOLE) — FDA approval
omeprazole DR
→
Oct 22, 2025
approval
LOFEXIDINE HYDROCHLORIDE — FDA approval
LOFEXIDINE HYDROCHLORIDE
→
Oct 17, 2025
approval
CLOMIPHENE CITRATE — FDA approval
CLOMIPHENE CITRATE
→
Oct 15, 2025
recall
GenoGenix LLC recall (Cls II)
Novitium Pharma LLC
→
May 9, 2025
approval
BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE (ASPIRIN) — FDA approval
Novitium Pharma LLC
→
Apr 30, 2025
approval
BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE (ASPIRIN) — FDA approval
BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE
→
Mar 13, 2025
approval
ACETAZOLAMIDE — FDA approval
ACETAZOLAMIDE
→
Nov 21, 2024
approval
BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE (ASPIRIN) — FDA approval
BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE
→
Nov 21, 2024
approval
BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE (ASPIRIN) — FDA approval
Novitium Pharma LLC
→
Oct 31, 2024
approval
LEVORPHANOL TARTRATE — FDA approval
LEVORPHANOL TARTRATE
→
Oct 31, 2024
approval
BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE (ASPIRIN) — FDA approval
Novitium Pharma LLC
→
Oct 31, 2024
approval
BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE (ASPIRIN) — FDA approval
Novitium Pharma LLC
→
Oct 23, 2024
approval
BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE (ASPIRIN) — FDA approval
BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE
→
Oct 9, 2024
approval
BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE (ASPIRIN) — FDA approval
Novitium Pharma LLC
→
Jun 12, 2024
approval
LEVORPHANOL TARTRATE — FDA approval
LEVORPHANOL TARTRATE
→
Feb 12, 2024
approval
BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE (ASPIRIN) — FDA approval
Novitium Pharma LLC
→
Feb 12, 2024
approval
BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE (ASPIRIN) — FDA approval
Novitium Pharma LLC
→
Feb 12, 2024
approval
BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE (ASPIRIN) — FDA approval
Novitium Pharma LLC
→